| Typicality: | 0.301 |
| Saliency: | 0.121 |
| in breast cancer patients | 2 | location |
| melatonin → inhibit → proliferation | 3 |
| melatonin → inhibit → cell production | 3 |
| negative | neutral | positive |
| 0.212 | 0.654 | 0.134 |
| Raw frequency | 6 |
| Normalized frequency | 0.121 |
| Modifier score | 0.500 |
| Perplexity | 76.743 |